BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37928432)

  • 1. Distant Metastasis is the Dominant Cause of Treatment Failure after Lateral Lymph Node Dissection in Patients with Lateral Lymph Node Metastasis: Results of the Large Multicenter Lateral Node Study in China.
    Li K; Wang F; Jiang Y; Hong G; Li Z; Liang J; Wu W; Xing W; Liu Q
    J Cancer; 2023; 14(17):3227-3237. PubMed ID: 37928432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China.
    Zhou S; Tang J; Liang J; Lou Z; Fu W; Feng B; Yang Y; Xiao Y; Liu Q
    Front Oncol; 2022; 12():916285. PubMed ID: 36033473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of therapeutic strategies for selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer with clinical suspected lateral lymph node metastasis.
    Liu Y; Bao M; Jiang Y; Li F; Xing W; Yang Z; Liu Q
    Front Oncol; 2023; 13():1271463. PubMed ID: 37886180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type.
    Morohashi H; Sakamoto Y; Miura T; Ichinohe D; Umemura K; Akaishi T; Sato K; Kuwata D; Yamazaki K; Wakiya T; Hakamada K
    Int J Colorectal Dis; 2021 Jun; 36(6):1251-1261. PubMed ID: 33527145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study.
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Yamaguchi S
    J Gastrointest Surg; 2021 Jul; 25(7):1866-1874. PubMed ID: 33078319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral Lymph Node Dissection for Locally Advanced Rectal Carcinoma: A Step-by-Step Description of Surgical Anatomical Planes During Cadaveric Dissection and Minimally Invasive Surgery.
    İsmail E; Kutlu B; Acar Hİ; Yörübulut M; Akkoca M; Kocaay AF; Elhan A; Kuzu MA
    Surg Laparosc Endosc Percutan Tech; 2024 Feb; 34(1):101-107. PubMed ID: 38134383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging.
    Yang X; Gu C; Hu T; Wei M; Meng W; Wang Z; Deng X; Zhou Z
    Tech Coloproctol; 2021 Apr; 25(4):425-437. PubMed ID: 33585985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review.
    Wong JSM; Tan GHC; Chia CS; Ong CJ; Teo MCC
    World J Gastrointest Surg; 2020 May; 12(5):247-258. PubMed ID: 32551030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
    Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
    Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management, treatment and prognostic significance of lateral lymph node metastases in rectal cancer-a regional cohort study.
    Agger E; Åkerlund V; Ekberg O; Jörgren F; Lydrup ML; Buchwald P
    Int J Colorectal Dis; 2021 Dec; 36(12):2707-2714. PubMed ID: 34487231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive lateral pelvic lymph nodes in low rectal cancer: should we change our practice now?
    Gartrell R; Hong MK; Baker A; Master M; Gibbs P; Arslan J; Croxford M; Yeung JM; Faragher IG
    ANZ J Surg; 2021 May; 91(5):947-953. PubMed ID: 33792140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.
    Schaap DP; Boogerd LSF; Konishi T; Cunningham C; Ogura A; Garcia-Aguilar J; Beets GL; Suzuki C; Toda S; Lee IK; Sammour T; Uehara K; Lee P; Tuynman JB; van de Velde CJH; Rutten HJT; Kusters M;
    Br J Surg; 2021 Mar; 108(2):205-213. PubMed ID: 33711144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
    Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
    BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy.
    Ozaki K; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Abe H; Ushiku T; Ishihara S
    Int J Colorectal Dis; 2022 Feb; 37(2):467-473. PubMed ID: 35064299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.